Hemolytic uremic syndrome following autologous peripheral blood stem cell transplantation in a patient with malignant lymphoma
- 1 May 1997
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 19 (10) , 1045-1047
- https://doi.org/10.1038/sj.bmt.1700791
Abstract
Hemolytic uremic syndrome (HUS) has been reported in patients receiving bone marrow transplantation. However, only a few cases of HUS following autologous peripheral blood stem cell transplantation (PBSCT) have been reported. We present a case of HUS developing after autologous PBSCT in a 40-year-old man with non-Hodgkin's lymphoma. It appears that the chemotherapeutic agents administered during the conditioning regimen for PBSCT may have played an important role in the development of HUS in our patient. In the present case, the combination therapy of vincristine, methylprednisolone, and ticlopidine hydrochloride was effective.Keywords
This publication has 0 references indexed in Scilit: